AGTC Moves Past Biogen With Ophthalmic Gene Therapy

 
• By Joseph Haas
  
Eye test in France
AGTC is advancing two gene therapies for rare retinal disorders
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies